Production (Stage)
Ondine Biomedical Inc.
OBIMF
$0.14
$0.00392.87%
OTC PK
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -2.54% | 38.96% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -2.54% | 38.96% | |||
| Cost of Revenue | -2.54% | 20.98% | |||
| Gross Profit | -2.55% | 50.18% | |||
| SG&A Expenses | -2.56% | 30.49% | |||
| Depreciation & Amortization | -2.59% | -3.02% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.57% | 47.84% | |||
| Operating Income | 2.56% | -48.81% | |||
| Income Before Tax | 2.57% | -46.52% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 2.57% | -46.52% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 2.57% | -46.52% | |||
| EBIT | 2.56% | -48.81% | |||
| EBITDA | 2.57% | -49.21% | |||
| EPS Basic | 2.22% | -15.38% | |||
| Normalized Basic EPS | 2.38% | -15.07% | |||
| EPS Diluted | 2.22% | -15.38% | |||
| Normalized Diluted EPS | 2.38% | -15.07% | |||
| Average Basic Shares Outstanding | 0.00% | 27.44% | |||
| Average Diluted Shares Outstanding | 0.00% | 27.44% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||